Bessemer Group’s Pliant Therapeutics PLRX Stock Holding History

Bessemer Group’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Hold	532,079	–	–	﹤0.01%	1117
2026 Q1	$670K	Hold	532,079	–	–	﹤0.01%	1052
2025 Q4	$649K	Hold	532,079	–	–	﹤0.01%	1068
2025 Q3	$787K	Sell	532,079 -39	-0%	-$60	﹤0.01%	724
2025 Q2	$618K	Hold	532,118	–	–	﹤0.01%	761
2025 Q1	$718K	Sell	532,118 -56	-0%	-$340	﹤0.01%	786
2024 Q4	$7.01M	Hold	532,174	–	–	0.01%	354
2024 Q3	$5.96M	Buy	532,174 +95	+0%	+$1.19K	0.01%	389
2024 Q2	$5.72M	Hold	532,079	–	–	0.01%	353
2024 Q1	$7.93M	Hold	532,079	–	–	0.01%	328
2023 Q4	$9.64M	Hold	532,079	–	–	0.02%	302
2023 Q3	$9.23M	Hold	532,079	–	–	0.02%	274
2023 Q2	$9.64M	Buy	532,079 +1,183	+0.2%	+$28K	0.02%	260
2023 Q1	$14.1M	Sell	530,896 -23,995	-4%	-$683K	0.03%	230
2022 Q4	$10.7M	Sell	554,891 -34,375	-6%	-$719K	0.03%	248
2022 Q3	$12.3M	Buy	589,266 +51,887	+10%	+$993K	0.03%	230
2022 Q2	$4.3M	Hold	537,379	–	–	0.01%	318
2022 Q1	$3.77M	Hold	537,379	–	–	0.01%	270
2021 Q4	$7.25M	Hold	537,379	–	–	0.01%	226
2021 Q3	$9.07M	Hold	537,379	–	–	0.02%	222
2021 Q2	$15.6M	Hold	537,379	–	–	0.03%	211
2021 Q1	$21.1M	Hold	537,379	–	–	0.05%	202
2020 Q4	$12.2M	Hold	537,379	–	–	0.03%	207
2020 Q3	$12.2M	Hold	537,379	–	–	0.04%	195
2020 Q2	$17.4M	Buy	+537,379	New	+$14.3M	0.06%	191

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bessemer Group's PLRX Position: Q2 2026 in Review

Bessemer Group held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 532,079 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Bessemer Group first reported a position in PLRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $21.1M in Q1 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Bessemer Group held 532,079 shares of Pliant Therapeutics worth $606K as of Q2 2026.
Bessemer Group left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1117 holding.
Bessemer Group first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 25 quarters since.
Bessemer Group's Pliant Therapeutics position peaked at $21.1M in Q1 2021.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.